help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, S.
Right arrow Articles by Sherwood, O. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, S.
Right arrow Articles by Sherwood, O. D.
Endocrinology Vol. 139, No. 11 4726-4734
Copyright © 1998 by The Endocrine Society


ARTICLES

Monoclonal Antibodies Specific for Rat Relaxin. X. Endogenous Relaxin Induces Changes in the Histological Characteristics of the Rat Vagina During the Second Half of Pregnancy

Shuangping Zhao and O. D. Sherwood

Department of Molecular and Integrative Physiology (S.Z., O.D.S.) and the College of Medicine (O.D.S.), University of Illinois at Urbana-Champaign, Urbana, Illinois 61801

Address all correspondence and requests for reprints to: Dr. O. D. Sherwood, Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, 407 South Goodwin Ave, Urbana, Illinois 61801. E-mail: od-sherw{at}uiuc.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This study employed morphometric analysis to evaluate changes in the histological characteristics that accompany relaxin-induced growth and softening of the vagina during the second half of rat pregnancy.

There were three treatment groups (N = 4/group). Five milligrams of a monoclonal antibody for rat relaxin, designated MCA1, were injected iv daily on days 12–21 of gestation to treatment group MCA1. Control groups received either 5 mg of monoclonal antibody for fluorescein (MCAF; monoclonal antibody control) or 0.5 ml PBS (vehicle control). Vaginas were removed on day 22 of pregnancy, fixed in 10% neutral-buffered formalin, and embedded in paraffin. Tissue sections (5 µm) were stained with Gomori’s trichrome to visualize collagen, or orcein to visualize elastin. Measurements were performed with a light microscope equipped with a video camera connected to a computer. Within the vaginal stroma, the density of collagen fiber bundles was lower, the length of elastin fibers was shorter, and the cross-sectional area and wall thickness of arteries were greater in relaxin-replete control rats than in relaxin-deficient MCA1-treated rats. These relaxin-induced changes in the stroma appear to account, at least in part, for the hormone’s softening effect on the vagina. Within the epithelium, there were approximately 2-fold more basal and mucus-secreting cells in relaxin-replete control rats than in MCA1-treated rats. The relaxin-induced accumulation of epithelial cells appears to contribute to vaginal growth.

We conclude that relaxin plays a role in preparing the vagina as well as the cervix for rapid and safe delivery in pregnant rats.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IN THE RAT, relaxin is produced and secreted by the corpora lutea throughout the second half of the 23-day gestation period (1). For more than 10 yr it has been known that endogenous relaxin enables rapid and safe delivery of the fetuses by promoting both growth and softening of the cervix (2, 3, 4, 5). Recent studies in our laboratory demonstrated that growth of the vagina is also relaxin-dependent in pregnant rats (6, 7). After constant sc infusion of porcine relaxin into ovariectomized estrogen- and progesterone-treated rats during the second half of pregnancy, the vaginal wet weight, dry weight, and DNA content were increased more than 1.5-fold compared with relaxin-deficient controls (6). Also, when endogenous relaxin was neutralized throughout the second half of pregnancy with a monoclonal antibody designated MCA1 that is specific for rat relaxin, vaginas had lower wet weight, dry weight, and DNA content, as well as smaller length, diameter, and inner surface area than those obtained from controls (7). It seems likely that relaxin acts directly on the vagina; specific and saturable relaxin binding sites were found in epithelial and smooth muscle cells of the vagina (7). Relaxin’s effects on the tensile properties of the vagina have not been reported.

A fundamental step toward a better understanding of the mechanism(s) whereby relaxin brings about its actions on the vagina is to examine its effects on the histological characteristics of the tissue. The histological changes associated with relaxin-induced growth and softening of the rat cervix during pregnancy were reported (8). Qualitative and quantitative analysis of cervical histological characteristics showed that in relaxin-deficient MCA1-treated rats, the epithelial cell density was lower, the collagen fiber bundles were more compact, the elastin fibers were longer, and the arteries had smaller cross-sectional area than in controls (8). Relaxin had no apparent effect on the height of the epithelial cell layer (8). The vagina and cervix are contiguous and share similar structural features, such as a lumen lined with epithelial cells and a stroma rich in collagen and elastin fibers.

We hypothesized that relaxin promotes vaginal softening and does so by inducing histological changes that are similar to those that occur in the cervix. Accordingly, there were two objectives to this study. The first objective was to determine if relaxin promotes vaginal softening during the second half of pregnancy. The second objective was to determine the effects of relaxin on the histological characteristics of the vagina during this period. To accomplish both objectives, endogenous circulating rat relaxin was neutralized with monoclonal antibody MCA1 throughout the second half of pregnancy.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Primiparous Sprague-Dawley-derived rats (Harlan Sprague-Dawley, Indianapolis, IN) were bred at approximately 90 days of age. The day that sperm were found in the vagina was designated day 1 of pregnancy. The animals arrived on day 3 and were housed individually. Rats had free access to water and Teklad 6% mouse/rat diet 7002 (Harlan/Teklad, Madison, WI), and they were maintained in a light-controlled room with alternating 14 h of light (0700–2100 h) and 10 h of darkness at a temperature of 23–25 C. From day 8, the light schedule was altered to 2100–1100 h to synchronize more precisely the stage of gestation among rats (9). On day 9 of pregnancy, the animals were laparotomized under ether anesthesia, and the number of implantation sites was determined. Only rats with eight or more implantation sites were used in the experiment because serum relaxin levels are directly related to the number of conceptuses in rats with small litters (10). The animal experimentation described in this study was approved by the University of Illinois Laboratory Animal Advisory Committee.

Treatments
Pregnant rats were randomly divided into three groups: MCA1, MCAF (monoclonal antibody for fluorescein; monoclonal antibody control), and PBS (vehicle control). Endogenous relaxin was neutralized with a monoclonal antibody for rat relaxin designated MCA1 as previously described (4, 5, 7, 8, 11, 12). In brief, five milligrams of MCA1 were injected into unanesthetized restrained rats once daily via tail vein between 0900–1100 h from days 12–21 of pregnancy. Control rats received either 5 mg MCAF or 0.5 ml PBS.

Effects of endogenous relaxin on vaginal softening
There were six rats per treatment group. Rats were anesthetized with ether and killed by cervical dislocation at 0900 h on day 22. The fetuses were counted, removed from the uterus, cleaned, and weighed. Both the vagina and the cervix were quickly removed, trimmed of fat and connective tissue, and weighed. Vaginas were placed in ice-cold Krebs-Ringer bicarbonate buffer (pH 7.5) until their extensibilities were determined approximately 1 h later.

Vaginal extensibility was determined as described previously for cervices (3) with modifications. In brief, a 1.5 x 1 cm strip was cut from each vagina. The strip was suspended between two 1 cm wide stainless steel tissue clamps (constructed by the University of Illinois School of Life Sciences Machine Shop), so that 1 cm x 1 cm of tissue was suspended between the two clamps. The vaginal strip was placed in a 60 ml organ bath containing Krebs-Ringer bicarbonate buffer oxygenated with 95% O2 –5% CO2. The lower clamp was fixed to the bottom of the organ bath, and the upper clamp was mobile and connected to a Grass FT03 force displacement transducer (Grass Instruments, Quincey, MA). The temperature was maintained at 37 C by circulating water through the outer chamber of the organ bath. Transducers were calibrated in grams before the measurements were started, and tension generated within 1 cm2 strips of vaginal tissue was expressed in grams. Outputs from the transducers were recorded on a Macintosh computer. For each vaginal strip, the distance between the two clamps was gradually increased until a slight increase in tension was recorded. This was the resting tension of the tissue. Each vaginal strip was allowed to equilibrate for 15 min. The distance between the two hooks was then increased by 2-mm increments at 15-min intervals until a total of 14 mm extension was applied to each vaginal strip. Tension developed within the vaginal tissue immediately after extension was recorded as initial tension, and that tension remaining within the tissue 15 min after extension was recorded as final tension. Tension that developed at extension was plotted vs. millimeters of extension. The slope of the linear regression of grams tension/millimeter extension for each treatment group was determined.

Effects of endogenous relaxin on vaginal histology
Four rats from each of groups MCA1, MCAF, and PBS were anesthetized with ether and killed by cervical dislocation at 0900 h on day 22 of pregnancy. Cervices and vaginas were quickly removed, cleaned, and weighed. Fetal number and fetal weights were determined. Each vagina was fixed whole in 10% neutral-buffered formalin (NBF) for 2 h. After this short prefixation, the vagina was cut in cross-section at two places to obtain a cephalic piece, middle piece, and caudal piece. Vaginal pieces were fixed in NBF for an additional 24 h, then dehydrated in an ascending series of ethanol, cleared with xylene, embedded in paraffin, and sectioned to obtain 5 µm thick sections (13). Sections were then stained with Gomori’s trichrome for collagen or orcein for elastin (13).

Morphometric analysis of the vagina was performed with an Olympus Corp. (Mellville, NY) BH-2 light microscope equipped with a video camera connected to a Power Macintosh 7100/66 computer. Images were analyzed digitally using the public domain NIH image program (developed at NIH and available from the Internet by anonymous FTP from zippy.nimh.nih.gov or on floppy disk from the National Technical Information Service (Springfield, VA), part number PB95–500195GEI). Data were obtained from four rats/group, three vaginal blocks (cephalic, middle, and caudal pieces)/rat, and four sections (approximately 20 µm apart)/block. Since five randomly selected fields/section were examined for each histological feature, a total of 60 fields per animal and 240 fields per group were analyzed.

The influence of relaxin on vaginal stroma or stroma plus adventitia was determined by analyzing the following: total cross-sectional area and thickness of the stroma, density of collagen fiber bundles in the stroma, length of elastin fibers in the stroma plus adventitia, cross-sectional area of arterial lumina in the stroma plus adventitia, and thickness of arterial walls in the stroma plus adventitia. To measure collagen density all the collagen fibers in a field were highlighted, and the number of highlighted pixels was divided by the total number of pixels in the field and expressed as a percentage of the field. To measure elastin fiber length, more than 10 elastin fibers were measured in each field. Thus, the lengths of more than 2,400 elastin fibers were measured per group. The cross-sectional area of 240 arteries (one per field) were determined per group. The arterial walls appeared to be of uniform thickness. Therefore, one determination was made of wall thickness per artery.

Analysis of vaginal stroma cells is complicated by the presence of several cellular components. These include isolated stromal cells (fibroblasts, mast cells, polymorphonuclear leukocytes, etc.), cells associated with blood vessels and extensive smooth muscle cell bundles that are located near the periphery of the vagina (Fig. 1Go). A recent study in our laboratory demonstrated that smooth muscle cells in cervical and vaginal stroma do not proliferate extensively during the second half of rat pregnancy (14). Accordingly, only isolated stromal cells located between the epithelium and the smooth muscle cell bundles were analyzed without regard to cell type. Analysis of this predominant stromal area included density of stromal cells (cells/mm2) and total stromal cells per cross-sectional area of the vagina.



View larger version (80K):
[in this window]
[in a new window]
 
Figure 1. Photomicrographs of Gomori’s trichrome-stained cross sections of vaginas obtained on day 22 of pregnancy from PBS-treated control (A) and MCA1-treated (B) rats. sm, Smooth muscle; bm, basement membrane. Bar in A, 1,000 µm. Both figures are the same magnification.

 
The influence of relaxin on vaginal epithelial cells was also determined. All portions of the epithelium were analyzed. In a few cases epithelial locations were judged unsuitable for analysis because of apparent modifications of the epithelium that were likely due to sectioning or other processing steps. Initially, the height and circumference of the entire epithelium were determined. Epithelial cells can be differentiated histologically into two strata, the basal cell stratum that is located proximal to the basement membrane and the mucus-secreting cell stratum that is located proximal to the lumen. To determine if relaxin has different effects on the two strata, they were analyzed individually. The following features were analyzed: height of basal cell stratum, height of mucus-secreting cell stratum, layers of cells in each stratum, and total cells in each stratum per total circumference of the vagina. The total cells in each stratum per circumference were determined by multiplying the cell numbers in each stratum/mm basement membrane by the total circumference of the epithelium.

Statistical analysis
All data were analyzed by one-way ANOVA and Tukey’s test.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effects of endogenous relaxin on vaginal softening
Mean number of implantation sites on day 9 and mean number of fetuses on day 22 of pregnancy did not differ among the three treatment groups (Table 1Go). Consistent with previous findings, the mean vaginal wet weights and cervical wet weights were much greater (P < 0.01), and mean fetal weights were slightly lower (P < 0.05) in controls than in MCA1-treated rats (7, 11, 15).


View this table:
[in this window]
[in a new window]
 
Table 1. Mean (± SE) number of implantation sites on day 9, number of fetuses, fetal weight, vaginal wet weight, and cervical wet weight on day 22 of pregnancy in PBS-, MCAF-, and MCA1-treated rats

 
Figure 2Go shows the tensile properties of vaginas obtained from MCAF-, PBS-, and MCA1-treated rats. With all three groups, the initial tension did not increase until the tissue was extended 6 mm. At subsequent extensions, the initial rise in tension at extension was followed by a marked decay in tension over the 15-min period between extensions. Over the range from 8 mm to 14 mm extension, the mean tensions generated within vaginas obtained from MCAF- and PBS-treated control rats were significantly lower at both initial tension (Fig. 2AGo), and final tension (Fig. 2BGo) than those generated within vaginas obtained from MCA1-treated rats.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 2. Mean (± SE) initial tension (A) and final tension (B) in vaginas obtained from MCA1-, MCAF- and PBS-treated rats on day 22 of pregnancy. Asterisks indicate a significant difference in the slope of MCA1 from controls over the range from 8- to 14-mm extension (*, P < 0.05; **, P < 0.01).

 
Effects of endogenous relaxin on vaginal histology
There were no differences among the cephalic, middle, and caudal pieces of the vagina; therefore, the results of the three blocks per animal were pooled for analysis. There were also no differences in histological characteristics of the vagina between PBS- and MCAF-treated controls. Therefore, representative photographs are presented from only PBS-treated animals.

Morphometric analysis of relaxin’s effects on the vaginal stroma are shown in Fig. 3Go. The total cross-sectional area of vaginal stroma did not differ among treatment groups (Fig. 3AGo). However, in vaginas obtained from control rats the thickness of the stroma (Fig. 3BGo), the density of collagen fiber bundles (Fig. 3CGo), and the length of elastin fibers (Fig. 3DGo) were lesser; and the cross-sectional area of arterial lumina (Fig. 3EGo) and thickness of arterial walls (Fig. 3FGo) were greater than in vaginas obtained from relaxin-deficient MCA1-treated rats. Relaxin also influenced the cellular composition of the vaginal stroma. Both the density (Fig. 4AGo) and total number of stromal cells per cross-sectional area of vagina (Fig. 4BGo) were greater in relaxin-replete controls than in relaxin-deficient MCA1-treated rats.



View larger version (54K):
[in this window]
[in a new window]
 
Figure 3. Mean (+ SE) total cross-sectional area of stroma (A), thickness of stroma (B), density of collagen fiber bundles (C), length of elastin fibers (D), cross-sectional area of arterial lumina (E), and thickness of arterial walls (F) in vaginas obtained from PBS-, MCAF-, and MCA1-treated rats on day 22 of pregnancy. Asterisks indicate a significant difference from both controls (*, P < 0.05; **, P < 0.01)); #, difference (P < 0.05) from PBS control only. Number of animals indicated at the base of each column.

 


View larger version (33K):
[in this window]
[in a new window]
 
Figure 4. Mean (+ SE) stromal cell density (A) and total stromal cells/cross-section of the entire vagina (B) in vaginas obtained from PBS-, MCAF-, and MCA1-treated rats on day 22 of pregnancy. Asterisks indicate a significant difference from controls (*, P < 0.05). Number of animals indicated at the base of each column.

 
Figure 5Go contains photomicrographs of sections of vaginas obtained from PBS- and MCA1-treated animals. Differences in the histological characteristics of both the stroma and the epithelium of vaginas obtained from control and relaxin-deficient rats were so marked they were readily apparent by visual examination. Note the lower density of collagen fiber bundles in relaxin-replete control rats (Fig. 5Go, A and B) than in relaxin-deficient MCA1-treated rats (Fig. 5Go, C and D). Also it is obvious that the height of the entire vaginal epithelium in relaxin-replete rats (Fig. 5AGo) was greater than that in relaxin-deficient rats (Fig. 5CGo). The difference in height of the epithelium was attributable to differences in the thickness of both the mucus-secreting cells (compare Fig. 5AGo with Fig. 5CGo) and basal cells (compare Fig. 5BGo with Fig. 5DGo).



View larger version (142K):
[in this window]
[in a new window]
 
Figure 5. Photomicrographs of Gomori’s trichrome-stained cross-sections of vaginas obtained on day 22 of pregnancy from PBS-treated control (A, B) and MCA1-treated (C, D) rats. bc, Basal epithelial cells; msc, mucus-secreting epithelial cells; lu, lumen; black arrow, collagen fiber bundles; white arrow, amorphous ground substance. Bar in C, 100 µm. A and C are the same magnification. Bar in D, 25 µm. B and D are the same magnification.

 
Morphometric analysis of relaxin’s effects on the vaginal epithelium are shown in Figs. 6Go and 7Go. Both the height of entire epithelium and the circumference of the vaginal lumen were greater in controls than in relaxin-deficient MCA1-treated rats (Fig. 6Go). Analysis of the two epithelial cell strata indicated that the height of both the basal cells and mucus-secreting cells were greater in relaxin-replete rats than in relaxin-deficient rats (Fig. 7Go, A and B). This finding is attributable, at least in part, to more layers of both basal and mucus-secreting cells in the relaxin-replete groups (Fig. 7Go, C and D). Because both the circumference of the lumen and the number of cell layers per stratum are greater in relaxin-replete animals, the total epithelial cells in each stratum per circumference of the vagina in relaxin-replete animals is more than twice that in the relaxin-deficient MCA1-treated animals (Fig. 7Go, E and F). There was no difference among the three treatment groups in the ratio of mucus-secreting epithelial cells and basal epithelial cells (data not shown).



View larger version (39K):
[in this window]
[in a new window]
 
Figure 6. Mean (+ SE) total height (A), and circumference (B) of the epithelium in vaginas obtained from PBS-, MCAF-, and MCA1-treated rats on day 22 of pregnancy. Asterisks indicate a significant difference from controls (**, P < 0.01). Number of animals indicated at the base of each column.

 


View larger version (47K):
[in this window]
[in a new window]
 
Figure 7. Mean (+ SE) height of basal cell stratum (A), height of mucus-secreting cell stratum (B), basal cell layers (C), mucus-secreting cell layers (D), total basal cells (E), and total mucus-secreting cells (F) per circumference of the epithelium in vaginas obtained from PBS-, MCAF-, and MCA1-treated rats on day 22 of pregnancy. Asterisks indicate a significant difference from controls (**, P < 0.01). Both the total basal cells and total mucus-secreting cells per circumference were greater in MCAF controls than in PBS controls (*, P < 0.05). The reason for this difference between controls is not known. Number of animals indicated at the base of each column.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This study demonstrates that endogenous relaxin induces softening of the vagina during the second half of pregnancy in the rat. Additionally, this study provides the first evidence that endogenous relaxin induces changes in the histological characteristics of both the vaginal stroma and epithelium during rat pregnancy. Within the vaginal stroma, relaxin induces changes that are similar to those the hormone induces in the cervical stroma. Within the epithelium, relaxin promotes an approximately 2-fold increase in both basal and mucus-secreting cells.

The observation that the tension generated with extension of vaginas obtained from relaxin-deficient MCA1-treated rats on day 22 of pregnancy was significantly greater than that generated in vaginas obtained from controls can be interpreted to indicate that relaxin facilitates the passage of fetuses though the vagina as well as the cervix (5, 15) at delivery in rats.

Several of the relaxin-induced changes in the histological characteristics of the vaginal stroma may account for relaxin’s effects on vaginal extensibility (softening). These histological changes include reduction in the thickness of the stroma, density of collagen fiber bundles, and length of elastin fibers. The mechanisms whereby relaxin reduces the density of collagen fiber bundles and length of elastin fibers in its target tissues are poorly understood. The finding that vaginal blood vessels in MCA1-treated rats are smaller than in controls is consistent with previous evidence that relaxin causes blood vessel dilation in mouse uterine endometrium (16), rat myometrium (17), rat and pig cervix (8, 18), mouse mammary gland (19), and rat mammary nipple (12). Relaxin-induced enlargement of blood vessels could increase blood supply to support vaginal growth during the second half of pregnancy. The mechanism whereby relaxin causes blood vessel dilation is not understood. It has been postulated that relaxin may mediate its effects on vascular smooth muscle by increasing the production nitric oxide. Bani (20) recently reported that bovine vascular smooth muscle cells respond to relaxin in vitro by increasing the production of nitrites and intracellular levels of cGMP, the mediator of the cell response to nitric oxide (21). The finding that relaxin increases the thickness of arterial walls can be interpreted to indicate that relaxin induces proliferation of blood vessel cells. Burger and Sherwood (14) recently reported that the percentage of new cells surrounding cervical blood vessels at term was greater in relaxin-replete rats than in relaxin-deficient rats.

The finding that relaxin increases the number of stromal cells in the vagina is consistent with a study (16) that demonstrated that relaxin may synergize with steroids to promote proliferation of endometrial stromal cells. The influence of relaxin on the function of stromal cells is not clear. It was reported that relaxin promotes collagenase activity in cultures of human cervical stromal cells (22) and induces decidual transformation of endometrial stromal cells in mice (16).

Whereas relaxin-induced changes in the histological characteristics of the stroma appear to be largely responsible for softening of the vagina, the relaxin-induced accumulation of epithelial cells contributes to vaginal growth (6, 7). The observation that relaxin promotes epithelial cell growth by increasing both the number of epithelial cell layers and the total epithelial cells by about 2-fold is consistent with our previous finding that relaxin-replete rats have approximately a 2-fold greater vaginal DNA content than do relaxin-deficient rats (6, 7). The mechanism whereby relaxin brings about an increased in the number of vaginal epithelial cells is not known. The present findings can be interpreted to indicate that relaxin promotes cell proliferation and/or prevents apoptosis in the vaginal epithelium during the second half of pregnancy. Regardless of the mechanism whereby relaxin increases the accumulation of vaginal epithelial cells, the finding that the ratio of basal to mucus-secreting cells appears to remain constant seems noteworthy. We cannot presently explain this finding. The physiological significance of the dramatic increase in vaginal epithelial cells is not known with certainty. It seems likely that the increase in total epithelial cells contributes to the increase in the circumference of the vagina, which in turn contributes to rapid and safe delivery. Also, the increase in layers of mucus-secreting cells may facilitate birth by increasing lubrication of the birth canal. The relaxin-induced increase in vaginal epithelial cells may be beneficial to the mother rat. The increase in layers of both basal and mucus-secreting cells may protect the lower reproductive tract during the delivery.

Though the mechanisms whereby relaxin alters histological characteristics are presently unclear, two lines of evidence indicate that relaxin promotes tissue remodeling by similar mechanisms in the vagina, cervix, mammary gland, and nipples during the second half of rat pregnancy. First, relaxin-induced histological changes of the vagina are similar to those in the cervix (8), mammary gland (11), and mammary nipples (12). In all four tissues, the collagen density was lower; elastin fibers were shorter; and blood vessels were larger in control rats than in relaxin-deficient animals. Second, in all four tissues, specific relaxin-binding sites were found associated with the same cell types; namely, the epithelial cells, smooth muscle cells, and blood vessels (7, 23, 24, 25).

In summary, this study demonstrates that relaxin promotes softening of the vagina during the second half of rat pregnancy. Morphometrical analysis demonstrated that relaxin induces changes in the histological characteristics of the vaginal stroma that are similar to those the hormone induces in the cervical stroma. These changes likely contribute to vaginal softening. Relaxin also promotes a marked increase in vaginal epithelial cells. The increased epithelial cells may facilitate birth by contributing to increased vaginal lumen circumference and increased secretion of mucus into the birth canal. We conclude that relaxin plays a role in preparing the vagina as well as the cervix for rapid and safe delivery of the pups in pregnant rats.


    Acknowledgments
 
The authors thank Dr. R. Hess for assistance with the preparation of photomicrographs, B. Sylavong for supervision of animal care, the School of Life Science Artist Service for preparing the figures, and the College of Medicine Document Management Center for assisting with the preparation of the manuscript.

Received June 2, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Sherwood OD 1994 Relaxin. In: Knobil E, Neill JD (eds) The Physiology of Reproduction, ed 2. Raven Press, New York, vol 1:861–1009
  2. Downing SJ, Sherwood OD 1985 The physiological role of relaxin in the pregnant rat. I. The influence of relaxin on parturition. Endocrinology 116:1200–1205[Abstract]
  3. Downing SJ, Sherwood OD 1985 The physiological role of relaxin in the pregnant rat III. The influence of relaxin on cervical extensibility. Endocrinology 116:1215–1220[Abstract]
  4. Lao Guico-Lamm M, Sherwood OD 1988 Monoclonal antibodies specific for rat relaxin. II. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts birth in intact rats. Endocrinology 123:2479–2485[Abstract]
  5. Hwang J-J, Sherwood OD 1988 Monoclonal antibodies specific for rat relaxin. III. Passive immunization with monoclonal antibodies throughout the second half of pregnancy reduces cervical growth and extensibility in intact rats. Endocrinology 123:2486–2490[Abstract]
  6. Burger LL, Sherwood OD 1995 Evidence that cellular proliferation contributes to relaxin-induced growth of both the vagina and the cervix in the pregnant rat. Endocrinology 136:4820–4826[Abstract]
  7. Zhao S, Kuenzi MJ, Sherwood OD 1996 Monoclonal antibodies specific for rat relaxin. IX. Evidence that endogenous relaxin promotes growth of the vagina during the second half of pregnancy in rats. Endocrinology 137:425–430[Abstract]
  8. Lee AB, Hwang J-J, Haab LM, Fields PA, Sherwood OD 1992 Monoclonal antibodies specific for rat relaxin. VI. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts histological changes associated with cervical softening at parturition in rats. Endocrinology 130:2386–2391[Abstract]
  9. Sherwood OD, Downing SJ, Golos TG, Gordon WL, Tarbell MK 1983 Influence of light-dark cycle on antepartum serum relaxin and progesterone immunoactivity levels and on birth in the rat. Endocrinology 113:997–1003[Abstract]
  10. Golos TG, Sherwood OD 1982 Control of corpus luteum function during the second half of pregnancy in the rat: a direct relationship between conceptus number and both serum and ovarian relaxin levels. Endocrinology 111:872–878[Abstract]
  11. Hwang J-J, Lee AB, Fields PA, Haab LM, Mojonnier LE, Sherwood OD 1991 Monoclonal antibodies specific for rat relaxin. V. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts development of the mammary apparatus and, hence, lactational performance in rats. Endocrinology 129:3034–3042[Abstract]
  12. Kuenzi MJ, Sherwood OD 1992 Monoclonal antibodies specific for rat relaxin. VII. Passive immunization with monoclonal antibodies throughout the second half of pregnancy prevents development of normal mammary nipple morphology and function in rats. Endocrinology 131:1841–1847[Abstract]
  13. Sheehan DC, Hrapchak BB 191 1980 Theory and Practice of Histotechnology. Battelle Press, Columbus, pp 40–58, 170–192, 198
  14. Burger LL, Sherwood OD 1998 Relaxin increases the accumulation of new epithelial and stromal cells in the rat cervix during the second half of pregnancy. Endocrinology 139:3984–3995[Abstract/Free Full Text]
  15. Hwang J-J, Shanks RD, Sherwood OD 1989 Monoclonal antibodies specific for rat relaxin. IV. Passive immunization with monoclonal antibodies during the antepartum period reduces cervical growth and extensibility, disrupts birth, and reduces pup survival in intact rats. Endocrinology 125:260–266[Abstract]
  16. Bani G, Maurizi M, Bigazzi M, Bani Sacchi T 1995 Effects of relaxin on the endometrial stroma. Studies in mice. Biol Reprod 53:253–262[Abstract]
  17. Vasilenko P, Mead JP, Weidmann JE 1986 Uterine growth-promoting effects of relaxin: A morphometric and histological analysis. Biol Reprod 35:987–995[Abstract]
  18. Winn RJ, O’Day-Bowman MB, Sherwood OD 1993 Hormonal control of the cervix in pregnant gilts. IV. Relaxin promotes changes in the histological characteristics of the cervix that are associated with cervical softening during late pregnancy in gilts. Endocrinology 133:121–128[Abstract]
  19. Bani G, Bani Sacchi T, Bigazzi M, Bianchi S 1988 Effects of relaxin on the microvasculature of mouse mammary gland. Histol Histopathol 3:337–343[Medline]
  20. Bani D 1997 Relaxin: a pleiotropic hormone. Gen Pharmacol 28:13–22[Medline]
  21. Ignarro LJ 1991 Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 41:485–490[CrossRef][Medline]
  22. Hwang J-J, Macinga D, Rorke EA 1996 Relaxin modulates human cervical stromal cell activity. J Clin Endocrinol Metab 81:3379–3384[Abstract]
  23. Kuenzi MJ, Sherwood OD 1995 Immunohistochemical localization of specific relaxin-binding cells in the cervix, mammary glands, and nipples of pregnant rats. Endocrinology 136:1367–1373[Abstract]
  24. Kuenzi MJ, Connolly BA, Sherwood OD 1995 Relaxin acts directly on rat mammary nipples to stimulate their growth. Endocrinology 136:2943–2947[Abstract]
  25. Min G, Sherwood OD 1996 Identification of specific relaxin-binding cells in the cervix, mammary glands, nipples, small intestine, and skin of pregnant pigs. Biol Reprod 55:1243–1252[Abstract]



This article has been cited by other articles:


Home page
EndocrinologyHome page
L. Yao, A. I. Agoulnik, P. S. Cooke, D. D. Meling, and O. D. Sherwood
Relaxin Acts on Stromal Cells to Promote Epithelial and Stromal Proliferation and Inhibit Apoptosis in the Mouse Cervix and Vagina
Endocrinology, May 1, 2008; 149(5): 2072 - 2079.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
J. L. Lowder, K. M. Debes, D. K. Moon, N. Howden, S. D. Abramowitch, and P. A. Moalli
Biomechanical Adaptations of the Rat Vagina and Supportive Tissues in Pregnancy to Accommodate Delivery
Obstet. Gynecol., January 1, 2007; 109(1): 136 - 143.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
C. S. Samuel
Relaxin: Antifibrotic Properties and Effects in Models of Disease
Clin. Med. Res., November 1, 2005; 3(4): 241 - 249.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
O. D. Sherwood
Relaxin's Physiological Roles and Other Diverse Actions
Endocr. Rev., April 1, 2004; 25(2): 205 - 234.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Zhao, P. A. Fields, and O. D. Sherwood
Evidence That Relaxin Inhibits Apoptosis in the Cervix and the Vagina during the Second Half of Pregnancy in the Rat
Endocrinology, June 1, 2001; 142(6): 2221 - 2229.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. D. Sherwood, L. M. Olson, S. Zhao, and H. R. Little
Inhibition of Nitric Oxide Synthase Activity Diminishes the Acute Effects of Relaxin on Growth, But Not Softening, of the Cervix in the Rat
Endocrinology, July 1, 2000; 141(7): 2458 - 2464.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. Zhao, C. S. Samuel, G. W. Tregear, F. Beck, and E. M. Wintour
Collagen Studies in Late Pregnant Relaxin Null Mice
Biol Reprod, March 1, 2000; 63(3): 697 - 703.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, S.
Right arrow Articles by Sherwood, O. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, S.
Right arrow Articles by Sherwood, O. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals